Syndicate Life Sciences

Hisar, India Founded: 2010 • Age: 16 yrs
Pharmaceutical drug manufacturing and distribution in India, focusing on affordable health solutions.

About Syndicate Life Sciences

Syndicate Life Sciences is a Healthcare company based in Hisar (India) founded in 2010. Pharmaceutical drug manufacturing and distribution in India, focusing on affordable health solutions. The company has 18 employees. Its Indian entity Syndicate Life Sciences Private Limited reported revenue of β‚Ή18.03 Cr. Syndicate Life Sciences offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Drugs and Pharmaceutical Distribution.

Company details

Syndicate Life Sciences is recognized as a trusted entity in the pharmaceutical sector, where a wide range of high-quality drugs, including tablets, capsules, syrup, dry syrup, powder, and injectables, is delivered at affordable prices across the country. The well-being of people is addressed through the provision of innovative and effective drugs that cater to various health needs. Operations are supported by manufacturing and business opportunities, ensuring accessibility and reliability in the market. This approach is evident in the companys commitment to quality and distribution efforts.

Key Metrics
  • Annual Revenue
    ₹18.03 Cr

    FY 2026 · +12% YoY

  • Net Profit
    ₹14.1 Lakh

    FY 2026 · 1% margin

  • EBITDA
    ₹63.4 Lakh

    FY 2026 · 4% margin

  • Employee Count
    18

Products & Services of Syndicate Life Sciences

Syndicate Life Sciences offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Tablets
Pharmaceutical Drugs

Tablets are manufactured and supplied as part of a range of drugs for health purposes

Capsules
Pharmaceutical Drugs

Capsules are provided within the assortment of high-quality drugs for medical applications

Board of directors of Syndicate Life Sciences Private Limited (Syndicate Life Sciences)

Syndicate Life Sciences Private Limited is the primary company behind Syndicate Life Sciences. The board of Syndicate Life Sciences Private Limited currently have 2 directors; the longest-serving is Nitin Bhayana, appointed in 2010.

DirectorDesignationAppointedTenureEntity
Nitin Bhayana
DIN 02898201
Director15 Feb 201016 yrs 9 moSyndicate Life Sciences Private Limited
Sagar Uppal
DIN 02883026
Director15 Feb 201016 yrs 9 moSyndicate Life Sciences Private Limited

Financials of Syndicate Life Sciences

Figures of Syndicate Life Sciences Private Limited, the primary company behind Syndicate Life Sciences, for FY 2026. Revenue was ₹18.03 Cr (+12% year on year). Net profit was ₹14.1 Lakh (1% margin). EBITDA was ₹63.4 Lakh (4% margin). Revenue has grown at a compounded annual rate of +17% over three years and +19% over five years.

  • ₹18.03 CrRevenue · FY 2026 · +12% YoY
  • ₹14.1 LakhNet profit · 1% margin
  • ₹63.4 LakhEBITDA · 4% margin
  • ₹22.9 LakhPaid-up capital
  • +17%Revenue CAGR, 3 years
  • +19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Syndicate Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Syndicate Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Syndicate Life Sciences

The website of Syndicate Life Sciences (syndicatelife.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Syndicate Life Sciences

Syndicate Life Sciences was founded in 2010.

Syndicate Life Sciences is headquartered in Hisar, India. It is registered at Hisar, Haryana, India.

Syndicate Life Sciences has 18 employees.

The primary company behind Syndicate Life Sciences, Syndicate Life Sciences Private Limited, reported revenue of β‚Ή18.03 Cr for FY 2026, up 12% year on year.

Syndicate Life Sciences is recognized as a trusted entity in the pharmaceutical sector, where a wide range of high-quality drugs, including tablets, capsules, syrup, dry syrup, powder, and injectables, is delivered at affordable prices across the country. The well-being of people is addressed through the provision of innovative and effective drugs that cater to various health needs. Operations are supported by manufacturing and business opportunities, ensuring accessibility and reliability in the market. This approach is evident in the companys commitment to quality and distribution efforts.

Syndicate Life Sciences offers Tablets and Capsules.

Syndicate Life Sciences operates through Syndicate Life Sciences Private Limited.

The legal entities of Syndicate Life Sciences currently have 2 directors, including Nitin Bhayana, Sagar Uppal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available